314 related articles for article (PubMed ID: 26139638)
1. Acid Suppressive Therapy for Stress Ulcer Prophylaxis in Noncritically Ill Patients.
Hong MT; Monye LC; Seifert CF
Ann Pharmacother; 2015 Sep; 49(9):1004-8. PubMed ID: 26139638
[TBL] [Abstract][Full Text] [Related]
2. Overuse of Acid-Suppression Therapy at an Urban Tertiary Hospital.
Redfern RE; Brown M; Karhoff KL; Middleton JL
South Med J; 2015 Dec; 108(12):732-8. PubMed ID: 26630894
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.
Barletta JF; Kanji S; MacLaren R; Lat I; Erstad BL;
J Crit Care; 2014 Dec; 29(6):955-60. PubMed ID: 25081626
[TBL] [Abstract][Full Text] [Related]
4. Impact of A Collaborative Strategy to Reduce the Inappropriate Use of Acid Suppressive Therapy in Non-Intensive Care Unit Patients.
Belfield KD; Kuyumjian AG; Teran R; Amadi M; Blatt M; Bicking K
Ann Pharmacother; 2017 Jul; 51(7):577-583. PubMed ID: 28622739
[TBL] [Abstract][Full Text] [Related]
5. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
[TBL] [Abstract][Full Text] [Related]
6. Stress Ulcer Prophylaxis in Neurocritical Care.
Barletta JF; Mangram AJ; Sucher JF; Zach V
Neurocrit Care; 2018 Dec; 29(3):344-357. PubMed ID: 28929324
[TBL] [Abstract][Full Text] [Related]
7. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
Zhou X; Fang H; Xu J; Chen P; Hu X; Chen B; Wang H; Hu C; Xu Z
BMC Gastroenterol; 2019 Nov; 19(1):193. PubMed ID: 31752703
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Histamine
Hammond DA; Kathe N; Shah A; Martin BC
Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
[TBL] [Abstract][Full Text] [Related]
9. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit.
Murphy CE; Stevens AM; Ferrentino N; Crookes BA; Hebert JC; Freiburg CB; Rebuck JA
Pharmacotherapy; 2008 Aug; 28(8):968-76. PubMed ID: 18657013
[TBL] [Abstract][Full Text] [Related]
10. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.
Buckley MS; Park AS; Anderson CS; Barletta JF; Bikin DS; Gerkin RD; O'Malley CW; Wicks LM; Garcia-Orr R; Kane-Gill SL
Am J Med; 2015 Aug; 128(8):905-13. PubMed ID: 25820164
[TBL] [Abstract][Full Text] [Related]
11. Stress-related mucosal bleeding in critically ill oncology patients.
Bruno JJ; Canada TW; Wakefield CD; Nates JL
J Oncol Pharm Pract; 2009 Mar; 15(1):9-16. PubMed ID: 18753185
[TBL] [Abstract][Full Text] [Related]
12. Stress Ulcer Prophylaxis.
Barletta JF; Bruno JJ; Buckley MS; Cook DJ
Crit Care Med; 2016 Jul; 44(7):1395-405. PubMed ID: 27163192
[TBL] [Abstract][Full Text] [Related]
13. Benefit of an electronic medical record-based alarm in the optimization of stress ulcer prophylaxis.
Saad EJ; Bedini M; Becerra AF; Martini GD; Gonzalez JG; Bolomo A; Castellani L; Quiroga S; Morales C; Leathers J; Balderramo D; Albertini RA
Gastroenterol Hepatol; 2018; 41(7):432-439. PubMed ID: 29895412
[TBL] [Abstract][Full Text] [Related]
14. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.
Barletta JF; Sclar DA
Pharmacoeconomics; 2014 Jan; 32(1):5-13. PubMed ID: 24271943
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
Reynolds PM; MacLaren R
Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
[TBL] [Abstract][Full Text] [Related]
16. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center.
Erstad BL; Camamo JM; Miller MJ; Webber AM; Fortune J
Crit Care Med; 1997 Oct; 25(10):1678-84. PubMed ID: 9377882
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
McCaleb RV; Gandhi AS; Clark SM; Clemmons AB
Ann Pharmacother; 2016 Jul; 50(7):541-7. PubMed ID: 27091869
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
Barkun AN; Adam V; Martel M; Bardou M
Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
[TBL] [Abstract][Full Text] [Related]
20. Stress ulcer prophylaxis in critically ill adult patients with sepsis at risk of gastrointestinal bleeding: a retrospective cohort study.
Huang M; Han M; Song Z; Kuang L
Intern Med J; 2023 Mar; 53(3):389-396. PubMed ID: 34697866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
